ORG Wealth Partners
NVAX icon

ORG Wealth Partners’s Novavax NVAX Stock Holding History

ORG Wealth Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$216 Buy
+20
New +$179 ﹤0.01% 2338

Other funds holding NVAX

Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
TSP Capital Management Group
TSP Capital Management Group Summit, New Jersey $397M AUM 31.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

ORG Wealth Partners's NVAX Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Novavax (NVAX) in Q3 2026: 20 shares worth $216. The stake represents ﹤0.01% of the portfolio and ranks #2338 among its holdings.

170 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • ORG Wealth Partners held 20 shares of Novavax worth $216 as of Q3 2026.
  • Novavax was a new ORG Wealth Partners position in Q3 2026.
  • Novavax made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2338 holding.
  • 170 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.